Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Dermatologic Clues to Internal Disease: Selected Case Stories and Clinical Pearls
Description
The talk presented selected dermatology case stories to show how skin findings can reveal internal disease and genetic syndromes. It reviewed Carney complex, highlighting mucosal and cutaneous lentigines, blue nevi, cutaneous myxomas, endocrine tumors such as pigmented adrenal disease and Cushing syndrome, and the autosomal dominant genetic basis. It then discussed hereditary leiomyomatosis and renal cell cancer, emphasizing dermal and uterine leiomyomas, aggressive renal cancers, fumarate hydratase mutations, and the need for early MRI screening and family counseling. Rothmund-Thomson syndrome was illustrated with childhood poikiloderma, sparse hair, radial defects, cataracts, and cancer risk, especially osteosarcoma in type 2 disease. The lecture also covered ASOP syndrome and related red/purple patches overlying plasmacytoma or other tumors, massive localized lymphedema with risk of angiosarcoma and squamous cell carcinoma, and ruckus localized lymphedema in obese or post-radiation patients, underscoring the importance of a complete exam. Additional examples included prurigo pigmentosa linked to dieting and ketosis, Lafora disease and CADASIL as neurocutaneous/neurologic disorders diagnosable by skin biopsy or related testing, pigmented breast cancer and pigmented Paget/Bowen disease, amyloidosis with waxy papules, purpura, and acquired cutis laxa, and insulin-derived amyloid nodules at injection sites that can affect glucose control. Overall, the talk emphasized careful skin examination as a clue to systemic illness and malignancy.
View moreConclusions
- The presentation’s main conclusion is that many striking skin findings are important clues to hidden systemic disease, so dermatologic examination can uncover serious internal disorders early.
- Carney complex is characterized by mucocutaneous lentigines, myxomas, and endocrine tumors, and recognizing the skin findings can point to a familial tumor syndrome.
- Leiomyomatosis with renal cancer is an autosomal dominant fumarate hydratase disorder in which skin leiomyomas and uterine fibroids should trigger early renal cancer screening and family counseling.
- Rothmund-Thomson syndrome presents with poikiloderma, sparse hair, and skeletal abnormalities, and RECQL4-related disease carries a notable osteosarcoma risk.
- Red or violaceous patches overlying bone or chest masses can signal paraneoplastic or tumor-associated processes such as AESOP syndrome, Hodgkin recurrence, or melanoma-associated Brenner sign.
- Massive localized lymphedema in severe obesity is not just a benign overgrowth but a lesion that can harbor or progress to angiosarcoma or squamous cell carcinoma, so it warrants complete examination and often excision.
- Chronic genital or perianal lymphedema-like changes can be caused by obesity, surgery, radiation, hidradenitis, cancer, or other lymphatic obstruction and should not be dismissed as simple dermatitis.
- Prurigo pigmentosa is an itchy reticulated eruption strongly linked to dieting, ketosis, weight loss, or bariatric states, and it tends to improve with diet change or tetracyclines rather than topical steroids.
- Skin biopsy can aid diagnosis even in neurologic disease, including Lafora disease, CADASIL, and synucleinopathies, showing that dermatopathology is increasingly useful beyond primary skin disorders.
- Pigmented lesions in the breast, genital, or acral skin are not always melanoma and may represent pigmented Paget disease, pigmented Bowen disease, or pigmented breast cancer, so pathology correlation is essential.
- Amyloidosis can produce purpura, waxy papules, and even acquired cutis laxa, and in some cases skin findings may be the first clue to an underlying plasma cell or lymphoproliferative disorder.
- Insulin-derived amyloidosis at injection sites can cause insulin resistance and dangerous dosing errors, so persistent injection-site lumps should be recognized as amyloidomas rather than simple lipohypertrophy.
- J Endocrinol Invest 2025; 48: 7
- JAMA Dermatol Mar 4, 2026
- Ann Hematol 2024; 193: 339
- Ann Haematol 2024; 103: 399
- JAAD Case Rep 2025; 63: 162
- Prac Neuro 2026; 26: 63
- JAMA Dermatol 2013; 149: 1117
- Ann Dermatol Venereol 2024; 151: 103256
- JAAD 2011; 65: 444
- Arch Dermatol 2007; 143: 1001
- Acta Derm Venerol 2019; 99: 452
- Obes Facts 2024; 17: 641
- Int J Dermatol 2017; 56: e16
- JAAD 2014; 71:320
- Int J Dermatol 2013; 52: 808
- Indian J Dermatol 2025; 70: 146
- Int J Dermatol 2020; 59: 876
- JAMA Derm 2023; 159: 864
- Am J Dermatolpathol 2003; 25: 117
- J Cut Med Surg 2025; 29: 545
- JAAD 2023; 89: 376
- J Cutan Pathol 2022; 49: 885
- Neurol Genet 2025; 11: e200288
- JAAD 2000; 43: 1125, 1128
- Cureus 2024; 16: e59550
- Ann Neurol 2025; 98; 273
- Mov Disord Clin Prac 2026; 13: 191
- J Neurol 2025; 272: 326
- Arch Dermatol 1989; 125: 536
- Indian Dermatol Online 2025; 16: 665
- Ann Dermatol 2014; 26: 747
- JAMA Dermatol 2010; 146: 1435
- JAAD 2008; 58: S32
- JAAD 2020; 6: 351
- NEJM 2025; 392: e50